{"id":219342,"date":"2023-04-26T17:08:22","date_gmt":"2023-04-26T09:08:22","guid":{"rendered":"http:\/\/www.namnewsnetwork.org\/?p=219342"},"modified":"2023-04-26T17:08:22","modified_gmt":"2023-04-26T09:08:22","slug":"albatroz-therapeutics-secures-3-million-to-develop-first-ever-therapy-blocking-a-universal-process-involved-in-the-growth-and-spread-of-cancerous-solid-tumors-and-arthritic-cartilage-degradation","status":"publish","type":"post","link":"http:\/\/namnewsnetwork.org\/?p=219342","title":{"rendered":"Albatroz Therapeutics Secures $3 Million to Develop First-Ever Therapy Blocking a Universal Process Involved in the Growth and Spread of Cancerous Solid Tumors and Arthritic Cartilage Degradation"},"content":{"rendered":"\n<p><strong>SINGAPORE, April 26 (Bernama<strong>-BUSINESS WIRE<\/strong>) &#8212; <\/strong><a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.albatroztherapeutics.com%2F&amp;esheet=53386657&amp;newsitemid=20230425005190&amp;lan=en-US&amp;anchor=Albatroz+Therapeutics&amp;index=1&amp;md5=f01e7fbdee99353f8751bfb1db57cd77\">Albatroz Therapeutics<\/a>, a biotechnology company targeting tissue remodeling to stop cancer growth and treat arthritis, today announced it has secured $3 million USD in funding led by Outram Bio and SEEDS Capital to accelerate the development of therapeutic antibodies against a novel target that degrades the extracellular matrix, a key contributor to cancer and arthritis. The company also received the <a href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.amgen.com.sg%2Fmedia%2Fnews-release%2F2023%2F03%2FAmgen-and-NSG-Biolabs-Announce-Albatroz-Therapeutics-As-Winner-of-First-Amgen-Golden-Ticket-in-Singapore&amp;esheet=53386657&amp;newsitemid=20230425005190&amp;lan=en-US&amp;anchor=first+Golden+Ticket+prize+from+Amgen&amp;index=2&amp;md5=6dc4d31f01607526d83f36fc687b64e9\">first Golden Ticket prize from Amgen<\/a> in Singapore, recognizing the viability of its science and business plan.<\/p>\n\n\n\n<p>Cancer that has metastasized, spreading to other parts of the body, is notoriously difficult to treat and accounts for most cancer deaths. Albatroz has secured exclusive rights on a highly specific and novel target that blocks tumor growth and recurrence, including a range of therapeutic antibodies that inhibit this target. <\/p>\n\n\n\n<p><a href=\"http:\/\/mrem.bernama.com\/viewsm.php?idm=45964\">http:\/\/mrem.bernama.com\/viewsm.php?idm=45964<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SINGAPORE, April 26 (Bernama-BUSINESS WIRE) &#8212; Albatroz Therapeutics, a biotechnology company targeting tissue remodeling to stop cancer growth and treat arthritis, today announced it has secured $3 million USD in funding led by Outram Bio and SEEDS Capital to accelerate the development of therapeutic antibodies against a novel target that degrades the extracellular matrix, a [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[315],"tags":[],"_links":{"self":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/219342"}],"collection":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=219342"}],"version-history":[{"count":1,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/219342\/revisions"}],"predecessor-version":[{"id":219344,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=\/wp\/v2\/posts\/219342\/revisions\/219344"}],"wp:attachment":[{"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=219342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=219342"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/namnewsnetwork.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=219342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}